← FDA Drug Approvals (Drugs@FDA)

CLOBETASOL PROPIONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAPTALIS PHARMS · Approved 2019-10-02

Drug application

FDA Application #
ANDA211494
Application type
Abbreviated New Drug Application (Generic)
Brand name
CLOBETASOL PROPIONATE
Generic name
CLOBETASOL PROPIONATE
Active ingredients
CLOBETASOL PROPIONATE
Dosage form
SOLUTION
Route
TOPICAL
Marketing status
Prescription
Sponsor
SAPTALIS PHARMS
Manufacturer
Micro Labs Limited
First approval
2019-10-02

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown